Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Foghorn Therapeutics Inc (FHTX)

Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Foghorn Therapeutics Inc 500 Technology Square Ste 700 Cambridge MA 02139 USA

https://foghorntx.com Employees: 116 P: 617-586-3100

Description:

Foghorn Therapeutics Inc. engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. Foghorn Therapeutics Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 323,654
Enterprise Value, $K 243,314
Shares Outstanding, K 42,586
Annual Sales, $ 34,160 K
Annual Net Income, $ -98,430 K
Last Quarter Sales, $ 6,890 K
Last Quarter Net Income, $ -22,980 K
EBIT, $ -97,360 K
EBITDA, $ -96,560 K
60-Month Beta 3.11
% of Insider Shareholders 9.07%
% of Institutional Shareholders 61.55%
Float, K 38,723
% Float 90.93%
Short Volume Ratio 0.35

Growth:

1-Year Return 109.83%
3-Year Return -38.61%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 08/08/24
Next Earnings Date 11/07/24
Earnings Per Share ttm -1.95
EPS Growth vs. Prev Qtr 23.73%
EPS Growth vs. Prev Year 35.71%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FHTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -29.23%
Profit Margin % -288.14%
Debt/Equity 0.00
Price/Sales 12.60
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.26
Interest Coverage -1.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar